Bank of America’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bank of America’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,000	Closed	-$428K	–	7517
2018 Q2	$428K	Buy	10,000 +9,311	+1,351%	+$426K	﹤0.01%	4991
2018 Q1	$45K	Buy	689 +322	+88%	+$22.8K	﹤0.01%	6089
2017 Q4	$27K	Buy	+367	New	+$30.4K	﹤0.01%	6326
2015 Q2	–	Sell	-12,644	Closed	-$6.23M	–	7446
2015 Q1	$6.23M	Buy	12,644 +12,622	+57,373%	+$4.89M	﹤0.01%	2269
2014 Q4	$8K	Sell	22 -167	-88%	-$49.7K	﹤0.01%	7141
2014 Q3	$36K	Sell	189 -44	-19%	-$9.67K	﹤0.01%	6728
2014 Q2	$56K	Sell	233 -189	-45%	-$38.4K	﹤0.01%	6575
2014 Q1	$108K	Buy	422 +66	+19%	+$20.2K	﹤0.01%	5938
2013 Q4	$70K	Buy	+356	New	+$63.3K	﹤0.01%	6370

Bank of America's LUMO Position: Q4 2024 in Review

Bank of America sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 1,800 shares — an estimated $6.97K sold.

Bank of America first reported a position in LUMO in Q2 2013 and held it in 42 quarters. The position peaked at $1.74M in Q1 2018. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

Bank of America reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Bank of America sold 1,800 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $6.97K.
Bank of America first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
Bank of America's Lumos Pharma, Inc. Common Stock position peaked at $1.74M in Q1 2018.
0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.